The Motley Fool

Have £3k to invest? 2 FTSE 100 dividend stocks I’d buy to boost my ISA

Image source: Getty Images

Dividend investing is a great way to build your wealth. Recurring payments from FTSE 100 firms increase shareholder returns by compounding. This helps you to buy more shares.

If you have £3k to invest, or indeed any other considerable amount, finding the best dividend stocks may seriously improve your investing returns.

5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!

According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…

And if you click here we’ll show you something that could be key to unlocking 5G’s full potential...

However, many companies have recently cancelled or reduced their dividend payments due to the global shutdown. This means finding reliable dividend payers is getting more difficult.

The best dividend stocks have two specific characteristics

Good dividend stocks, with wide economic moats and solid dividend cover, are becoming harder to find.

A wide economic moat is the sustainable advantage a company has over its competitors. This makes it harder for peers to copy a firm’s strategy. And solid dividend cover means a firm can cover its dividend payments with earnings. Usually, the higher the ratio, the less risky the dividend.

I think there are only a few dividend-paying companies on the FTSE 100 that have both these attributes. Two are listed below.

1. FTSE 100 stalwart GlaxoSmithKline

Pharmaceutical giant GlaxoSmithKline (LSE: GSK) is well-renowned for its innovative product pipeline. It also has a reputation for a huge repertoire of patent-protected drugs.

From Calpol to Beechams powders, and Horlicks to flu vaccines, Glaxo’s market-leading offerings pervade our daily lives. This makes it extremely hard for its peers to compete with its market positioning.

Moreover, Glaxo uses its extensive resources to continually bring to market new healthcare products. And its vast manufacturing and distribution capability will be used by the US government to supply 100 million doses of a COVID-19 vaccine.

Glaxo is currently trading around 1,435p and offers a relatively impressive 5.4% dividend yield. Some analysts estimate the company’s fair value around 1,800p. Consequently, it appears to be undervalued by the FTSE 100.

With a dividend cover ratio of 1.5, Glaxo is able to cover its payments with earnings. Usually, I like to see a ratio of 2.0 or above. However, given the current economic climate, I think Glaxo’s dividend ratio is acceptable.

2. BAE Systems

Defence and aerospace behemoth BAE Systems (LSE: BA) has long-standing relationships with many global customers. Indeed, one of the most notable is the US Department of Defense. And if US defence spending grows as predicted, the firm will likely benefit with sales.

BAE Systems leverages these historic relationships with technical know-how and impressive engineering capability. As a result, it has a huge advantage with respect to its peers.  

Currently trading on the FTSE 100 at around 503p, BAE sits below some analysts’ fair value estimate of 570p. This means there is potential for future capital gains from the shares.

In addition, the firm boasts a relatively good dividend yield of 4.6%. Moreover, the dividend ratio cover is 2.0. And with predictable and stable cash flows from long-term contracts, the payments are fairly low risk. It may be one of the best dividends for sale on the FTSE 100 right now.

If you have £3k to invest, I think you’ll prosper from having either, or both, of these dividend stocks in your portfolio. 

5 Stocks For Trying To Build Wealth After 50

Markets around the world are reeling from the coronavirus pandemic…

And with so many great companies trading at what look to be ‘discount-bin’ prices, now could be the time for savvy investors to snap up some potential bargains.

But whether you’re a newbie investor or a seasoned pro, deciding which stocks to add to your shopping list can be daunting prospect during such unprecedented times.

Fortunately, The Motley Fool is here to help: our UK Chief Investment Officer and his analyst team have short-listed five companies that they believe STILL boast significant long-term growth prospects despite the global lock-down…

You see, here at The Motley Fool we don’t believe “over-trading” is the right path to financial freedom in retirement; instead, we advocate buying and holding (for AT LEAST three to five years) 15 or more quality companies, with shareholder-focused management teams at the helm.

That’s why we’re sharing the names of all five of these companies in a special investing report that you can download today for FREE. If you’re 50 or over, we believe these stocks could be a great fit for any well-diversified portfolio, and that you can consider building a position in all five right away.

Click here to claim your free copy of this special investing report now!

Rachael FitzGerald-Finch owns shares of GlaxoSmithKline. The Motley Fool UK has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Our 6 'Best Buys Now' Shares

The renowned analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.

So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply enter your email address below to discover how you can take advantage of this.

I would like to receive emails from you about product information and offers from The Fool and its business partners. Each of these emails will provide a link to unsubscribe from future emails. More information about how The Fool collects, stores, and handles personal data is available in its Privacy Statement.